<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="issn">2980-2857</journal-id>
      <journal-title-group>
        <journal-title>Journal of Arrhythmia and Electrophysiology (JAE)</journal-title>
        <abbrev-journal-title>J Arrhythm Electrophysiol</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2980-2857</issn>
      <publisher>
        <publisher-name>Journal of Arrhythmia and Electrophysiology</publisher-name>
        <publisher-loc>Turkey</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.5281/zenodo.8024677</article-id>
      <article-categories>
        <subj-group>
          <subject>Health Sciences</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Irrigated Radiofrequency Catheter Ablation with Limited Fluoroscopy for Ventricular Arrhythmias in Children and Adolescents</article-title>
        <subtitle>Ventricular Arrhythmia Ablation in Children</subtitle>
      </title-group>
      <contrib-group>

  <contrib contrib-type="author">
    <name>
      <surname>Koca</surname>
      <given-names>Serhat</given-names>
    </name>
    <xref ref-type="aff" rid="aff1"/>
    <xref ref-type="corresp" rid="cor-1"/>
  </contrib>

  <contrib contrib-type="author">
    <name>
      <surname>Akdeniz</surname>
      <given-names>Celal</given-names>
    </name>
    <xref ref-type="aff" rid="aff1"/>
  </contrib>

  <contrib contrib-type="author">
    <name>
      <surname>Tuzcu</surname>
      <given-names>Volkan</given-names>
    </name>
    <xref ref-type="aff" rid="aff1"/>
  </contrib>

</contrib-group>

<aff id="aff1">
  Pediatric and Genetic Arrhythmia Center, Pediatric Cardiology, Istanbul Medipol University, Istanbul, Turkey</aff>

<author-notes>
  <fn fn-type="coi-statement">
    <label>Conflict of Interest</label>
    <p>The authors declare no conflict of interest.</p>
  </fn>

  <corresp id="cor-1">
    <bold>Corresponding author: Serhat Koca, MD</bold>, Pediatric and Genetic Arrhythmia Center, Pediatric Cardiology, Istanbul Medipol University, Istanbul, Turkey. Email: drserhatkoca@gmail.com</corresp>
</author-notes>
      <pub-date date-type="pub" iso-8601-date="2023-07-01" publication-format="electronic">
        <day>01</day>
        <month>07</month>
        <year>2023</year>
      </pub-date>
      <pub-date date-type="collection" iso-8601-date="2023-07-01" publication-format="electronic">
        <day>01</day>
        <month>07</month>
        <year>2023</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>9</lpage>
      <history>
        <date date-type="received" iso-8601-date="2023-04-07">
          <day>07</day>
          <month>04</month>
          <year>2023</year>
        </date>
        <date date-type="accepted" iso-8601-date="2023-05-15">
          <day>15</day>
          <month>05</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright (c) 2023 Serhat Koca; Celal Akdeniz; Volkan Tuzcu</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>Serhat Koca; Celal Akdeniz; Volkan Tuzcu</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://jaejournal.com/index.php/jaejournal/article/view/2" xlink:title="Irrigated Radiofrequency Catheter Ablation with Limited Fluoroscopy for Ventricular Arrhythmias in Children and Adolescents">Irrigated Radiofrequency Catheter Ablation with Limited Fluoroscopy for Ventricular Arrhythmias in Children and Adolescents</self-uri>
      <abstract abstract-type="structured">

    <sec sec-type="background">
        <title>Background</title>
        <p>There are insufficient studies regarding the use of irrigated catheters for ventricular arrhythmia ablations in pediatric patients; therefore, most of the information on this subject has been obtained from studies conducted with adults.</p>
    </sec>

    <sec sec-type="objective">
        <title>Objective</title>
        <p>This study aimed to assess the outcomes of irrigated catheter ablations performed using limited or zero fluoroscopy with the guidance of a three-dimensional electroanatomic mapping system in a pediatric ventricular arrhythmia patient group.</p>
    </sec>

    <sec sec-type="methods">
        <title>Methods</title>
        <p>Thirty-nine consecutive pediatric patients undergoing irrigated catheter ventricular arrhythmia ablations at a single tertiary center were enrolled in this study. All of the children underwent electrophysiological studies using EnSite NavX system guidance with limited or zero fluoroscopy. The ventricular arrhythmia ablations were performed using irrigated catheters in all of the patients.</p>
    </sec>

    <sec sec-type="results">
        <title>Results</title>
        <p>The mean age of the patients was 12 years old (range = 3.5–17 years) and the mean weight was 50 kg (range = 12–84 kg). The mean procedure time was 165 ± 53 minutes. No fluoroscopy was used in most of the patients (30/39, 77%), and acute success was achieved in 35 patients (89.7%). During a mean follow-up period of 26.7 ± 13.7 months, ventricular arrhythmias recurred in nine patients. Four of these patients underwent successful ablations again and remaining five were followed-up with medical therapy without problems. No complications were seen.</p>
    </sec>

    <sec sec-type="conclusion">
        <title>Conclusion</title>
        <p>Ventricular arrhythmia ablations can be performed safely and effectively using irrigated catheters in pediatric patients. In addition, successful radiofrequency ablations can be achieved using three-dimensional electroanatomic mapping system without fluoroscopy in most patients.</p>
    </sec>

</abstract>
      <kwd-group>
    <kwd>children</kwd>
    <kwd>open irrigated-tip catheter</kwd>
    <kwd>three-dimensional electroanatomic mapping system</kwd>
    <kwd>ventricular arrhythmia</kwd>
</kwd-group>
      <funding-group>
        <funding-statement>The authors state that the current study received no financial support.</funding-statement>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>File created by JATS Editor</meta-name>
          <meta-value>
            <ext-link ext-link-type="uri" xlink:href="https://jatseditor.com" xlink:title="JATS Editor">JATS Editor</ext-link>
          </meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>issue-created-year</meta-name>
          <meta-value>2023</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
		<title>Introduction</title>
      <p>Catheter ablations have been introduced as an effective method with an acceptable complication rate for the treatment of ventricular arrhythmias (VAs) in children and adolescents. However, the success rate obtained with VA catheter ablations is lower than that achieved in supraventricular arrhythmias.<xref ref-type="bibr" rid="BIBR-1"><sup>1</sup></xref><xref ref-type="bibr" rid="BIBR-2"><sup>2</sup></xref><xref ref-type="bibr" rid="BIBR-3"><sup>3</sup></xref><xref ref-type="bibr" rid="BIBR-4"><sup>4</sup></xref></p><p>The presence of deeper foci is one of the reasons of ablation failure.<xref ref-type="bibr" rid="BIBR-5"><sup>5</sup></xref> Radiofrequency ablation (RFA) with irrigated tip catheters enables the formation of deeper and more extensive lesions, thereby increasing the success rate.<xref ref-type="bibr" rid="BIBR-6"><sup>6</sup></xref><xref ref-type="bibr" rid="BIBR-7"><sup>7</sup></xref> Unfortunately, there is very limited experience in the use of an irrigated tip ablation catheter in the pediatric population, and the literature is scarce regarding the use of this catheter in pediatric VA patients.</p><p>This study presents the experiences of RFAs performed in pediatric and adolescent patients with VAs [ventricular tachycardia (VT), premature ventricular contraction (PVC)] using irrigated catheters via the guidance of a three-dimensional electroanatomic mapping system (3DMS) with zero or limited fluoroscopy in an electrophysiology center.</p>
   </sec>
    <sec>
		<title>Methods</title>
        <p><bold>Study Population</bold></p>
        <p>This single-center retrospective study included pediatric patients under 18 years old who underwent catheter ablations using open irrigated tip catheters (OITCs) (Cool Flex, 4 mm, 7F; Abbott/St. Jude Medical Inc., St. Paul, MN, USA) with the guidance of 3DMS (EnSite NavX system; Abbott/St. Jude Medical Inc.) due to VAs between July 2012 and March 2018.</p><p>The patients’ clinical features (history, prior medications, and treatments), physical examinations, electrocardiograms (ECGs), echocardiograms (ECHOs), Holter monitorings, ablation procedures, outcomes, complications, and follow-ups were evaluated.</p>
		  <p><bold>Electrophysiologic study, mapping, and ablation</bold></p>
        <p>The antiarrhythmic medications were withdrawn for a period of at least 5 half-lives. After receiving written consent from the patient’s parents, an electrophysiological study (EPS) and catheter ablation procedure were begun. The EPS and catheter ablation were performed under mild or deep sedation with local anesthesia, as long as the patient’s status was convenient, in order to preserve the VA. Therefore, the anesthetic level was adjusted according to the tolerance of the child and whether the arrhythmia was suppressed or not. The EPS started with the insertion of one sheath from the right femoral vein and one from the left femoral vein, and the endocardial right atrium and coronary sinus geometry were created with 3DMS guidance, without using fluoroscopy. The superior vena cava, His potential, and inferior vena cava were marked on the right atrium map. After the basic measurements (atrium-His interval, His-ventricle interval, PR-QRS-QT durations, basic cycle length, and Wenckebach point) were evaluated, the induction of tachycardia was attempted via extrastimulation and burst pacing from the right atrium and right ventricle, with or without intravenous metaproterenol sulfate and/or dobutamine provocation.</p><p>The radiofrequency (RF) lesions were created in the power-control mode with powers of 30 and 35 watts using an RF generator (Atakr II; Medtronic Inc., Minneapolis, MN, USA). When the RF was administered, the delivered power, impedance, and catheter temperature were recorded continuously. The RF energy was delivered at a target duration of 30 or 60 seconds. Two types of saline irrigation were carried out using a peristaltic pump (Cool Point; Abbott/St. Jude Medical Inc.) at 17 ml/min during the RF energy administration and at 2 ml/min without the RF energy. When a left ventricular-originating VA was determined, a femoral artery puncture was performed to carry out the retroaortic approach. The ablation and diagnostic catheters were introduced to the left ventricle retrogradely for mapping and ablation by means of fluoroscopy. In addition, fluoroscopy was also used in the evaluation of the association between the point selected as the RFA target in a left-sided VA and the coronary arteries. When a left-sided ablation was performed, 70 units/kg of heparin (with a maximum of 5000 units) was intravenously administered.</p><p>The programmed/incremental stimulation was carried out from the atrium and ventricle, with and without metaproterenol and/or dobutamine, 30 minutes after the final ablation. Acute procedure success was defined as no further inducible or spontaneous VT/PVC for 30 minutes after the final ablation lesion (n=31/39). When the PVCs could not be completely eliminated after the PVC ablation, if the PVC burden decreased more than 50% by Holter monitoring performed the next day (n=4/39), the ablation was accepted as successful.</p><p>After the procedures, the patients were followed up for one night under continuous cardiac monitoring. Each of the patients underwent an ECHO, 12-lead ECG, and 24-hour Holter monitoring before they were discharged. Those patients who underwent left-sided ablations were given 3–5 mg/kg of oral acetylsalicylic acid for 1 month. The outpatient follow-ups were scheduled for 1 month, 6 months, and yearly.</p>
		  <p><bold>Statistical analysis</bold></p>
		  <p>The data were analyzed using the Statistical Package for the Social Sciences version 17.0 (SPSS Inc., Chicago, IL, USA). They were presented as the count (%), mean ± standard deviation, and median ± interquartile range, as appropriate. The distribution of the variables was analyzed using the Kolmogorov-Smirnov test. The group comparisons were performed with a one-way analysis of variance. A p value of 0.05 was considered to be statistically significant.</p>
      </sec>
      <sec>
		  <title>Results</title>
        <p>A total of 39 patients (25 PVCs, 14 VTs, 18 females) with a mean age of 12.08 years old (range = 3.5–17 years) who underwent RFAs with OITCs due to VAs were included in this study. The arrhythmogenic origin was the right side in 33 patients and the left side in 6 patients. The demographic and clinical characteristics of the patients are presented in <xref ref-type="table" rid="tbl1">Table 1</xref>. Eight patients had failed ablation histories in another center, and 25 patients were receiving at least one antiarrhythmic medical treatment. The most common complaint was palpitation, but 9 patients were completely asymptomatic. Ablations were performed in three of the patients due to mild left ventricular dysfunction, which was thought to be associated with a VA, despite medical treatment. PVC-triggered polymorphic ventricular tachycardia and implantable cardioverter defibrillator (ICD) storm were found in one 14-year-old girl who was followed up with an ICD implanted due to the diagnosis of long QT. Also, many ICD shocks to true VTs were determined in the ICD recordings of this patient. ICD storm could not be completely controlled medically, and so successful PVC ablation was performed.</p>

<table-wrap id="tbl1">
    <label>Table 1</label>
    <caption>
        <title>Characteristics of all study participants</title>
    </caption>

    <table frame="hsides" rules="groups">
        <thead>
            <tr>
                <th>Characteristics</th>
                <th>Patients (n=39)</th>
            </tr>
        </thead>
        <tbody>
            <tr><td>Age (mean ± SD, years)</td><td>12.1 ± 3.0</td></tr>
            <tr><td>Sex (n, female/male)</td><td>18/21</td></tr>
            <tr><td>Weight (mean ± SD, kg)</td><td>49.8 ± 14.6</td></tr>
            <tr><td>Height (mean ± SD, cm)</td><td>152.4 ± 18.6</td></tr>

            <tr><td>Symptoms (n)</td><td></td></tr>
            <tr><td>&#160;&#160;Asymptomatic</td><td>9</td></tr>
            <tr><td>&#160;&#160;Dyspnea</td><td>1</td></tr>
            <tr><td>&#160;&#160;Pre-syncope</td><td>2</td></tr>
            <tr><td>&#160;&#160;Chest pain</td><td>5</td></tr>
            <tr><td>&#160;&#160;Palpitation</td><td>22</td></tr>
            <tr><td>&#160;&#160;Syncope</td><td>3</td></tr>

            <tr><td>PVC load (mean ± SD, %)</td><td>27.0 ± 10.0</td></tr>
            <tr><td>Heart disease, n (%)</td><td>9/39 (23%)*</td></tr>
            <tr><td>PVC/VT (n)</td><td>25/14</td></tr>

            <tr><td>Echocardiography</td><td></td></tr>
            <tr><td>&#160;&#160;SF (mean ± SD, %)</td><td>35.7 ± 4.74</td></tr>
            <tr><td>&#160;&#160;LVEDD (mean ± SD mm)</td><td>44.5 ± 5.58</td></tr>
            <tr><td>&#160;&#160;IVSD (mean ± SD mm)</td><td>7.83 ± 1.56</td></tr>

            <tr><td>Prior Therapy (n)</td><td></td></tr>
            <tr><td>&#160;&#160;No (n)</td><td>14</td></tr>
            <tr><td>&#160;&#160;Yes (n)</td><td>25</td></tr>
            <tr><td>&#160;&#160;Medical (n)</td><td>25</td></tr>
            <tr><td>&#160;&#160;&#160;&#160;Propranolol</td><td>8</td></tr>
            <tr><td>&#160;&#160;&#160;&#160;Metoprolol</td><td>13</td></tr>
            <tr><td>&#160;&#160;&#160;&#160;Verapamil</td><td>3</td></tr>
            <tr><td>&#160;&#160;&#160;&#160;Sotalol</td><td>4</td></tr>
            <tr><td>&#160;&#160;&#160;&#160;Propafenone</td><td>3</td></tr>
            <tr><td>&#160;&#160;&#160;&#160;Flecainide</td><td>3</td></tr>

            <tr><td>Ablation (n)</td><td>8</td></tr>
        </tbody>
    </table>

    <table-wrap-foot>
        <p>Values are given as count, % or mean ± SD as appropriate.</p>
        <p>IVSD, interventricular septum diastolic dimension; LVEDD, left ventricular end diastolic dimension; PVC, premature ventricular complex; SF, shortening fraction; VT, ventricular tachycardia.</p>
        <p>* 3 mild left ventricular dysfunction, 1 mild mitral insufficiency, 1 medically controlled dilated cardiomyopathy, 1 small ventricular septal defect, 1 arrhythmogenic right ventricular dysplasia, 1 long QT, and 1 operated atrial septal defect.</p>
    </table-wrap-foot>

</table-wrap>
		  <p>The ablation procedures failed in 4 of the patients (10.2%), all of whom were VT patients. In 4 patients with right ventricular outflow tract (RVOT)-originating PVCs, the PVC burden decreased more than 50% by Holter monitoring performed the next day. In the remaining 31 patients, VAs were completely eliminated by ablation. The acute success rate was 89.7%. Each of the 4 patients with failed ablations is being followed up with single or combined antiarrhythmic medical treatments. During the follow-up, the cardiac functions of the patients who developed dilated cardiomyopathy and mild left ventricular dysfunction normalized after their successful ablations.</p><p>The patients’ procedural data are presented in <xref ref-type="table" rid="tbl2">Table 2</xref> and <xref ref-type="table" rid="tbl3">Table 3</xref>. The procedure time was longer in those patients undergoing VA ablations than in those undergoing PVC ablations (194 ± 60.3 min and 148.8 ± 41.4 min, respectively, p = 0.01). Similarly, the average and maximal temperatures were higher in the VT ablations. When the patients were evaluated according to their previous ablation histories, the maximum deflection index (MDI) was higher in the patients referred to our clinic from an outside center due to a failed VA ablation attempt than in the patients without ablation histories (0.69 ± 0.15% and 0.51 ± 0.12%, respectively, p = 0.002) (<xref ref-type="table" rid="tbl4">Table 4</xref>).</p>
		 

<table-wrap id="tbl2">
    <label>Table 2</label>
    <caption>
        <title>Characteristics of all electrophysiologic studies and ablations</title>
    </caption>

    <table frame="hsides" rules="groups">
        <thead>
            <tr>
                <th>Electrophysiologic properties</th>
                <th>Patients (n=39)</th>
                <th>Range</th>
            </tr>
        </thead>
        <tbody>

            <tr><td>AH (ms, mean ± SD)</td><td>67.7 ± 14.8</td><td>(42–106)</td></tr>
            <tr><td>HV (ms, mean ± SD)</td><td>45.2 ± 8.1</td><td>(32–72)</td></tr>
            <tr><td>BCL (ms, mean ± SD)</td><td>729.0 ± 166.9</td><td>(480–1140)</td></tr>
            <tr><td>PR (ms, mean ± SD)</td><td>133.0 ± 18.0</td><td>(100–170)</td></tr>
            <tr><td>QRS (ms, mean ± SD)</td><td>78.3 ± 11.5</td><td>(55–110)</td></tr>
            <tr><td>QT (ms, mean ± SD)</td><td>351.8 ± 32.3</td><td>(300–430)</td></tr>
            <tr><td>WCL (ms, mean ± SD)</td><td>336.8 ± 67.0</td><td>(240–550)</td></tr>

            <tr><td><bold>Ablation Properties</bold></td><td></td><td></td></tr>

            <tr><td>Power</td><td></td><td></td></tr>
            <tr><td>&#160;&#160;Average (W, mean ± SD)</td><td>25.2 ± 8.3</td><td>(5–41)</td></tr>
            <tr><td>&#160;&#160;Maximum (W, median, 25th and 75th IQR)</td><td>35 (30–35)</td><td>(10–50)</td></tr>

            <tr><td>Temperature</td><td></td><td></td></tr>
            <tr><td>&#160;&#160;Average (°C, median, 25th and 75th IQR)</td><td>33 (30–36)</td><td>(26–57)</td></tr>
            <tr><td>&#160;&#160;Maximum (°C, median, 25th and 75th IQR)</td><td>34 (31–42)</td><td>(27–68)</td></tr>

            <tr><td>Energy</td><td></td><td></td></tr>
            <tr><td>&#160;&#160;Average (joule, mean ± SD)</td><td>968.0 ± 650.3</td><td>(58–2858)</td></tr>

            <tr><td>RF lesion (n)</td><td>9.6 ± 5.9</td><td>(1–25)</td></tr>
            <tr><td>Procedure time (min, mean ± SD)</td><td>165.0 ± 53.0</td><td>(80–317)</td></tr>
            <tr><td>Acute success (n, %)</td><td>35/39 (89.7%) *</td><td></td></tr>
            <tr><td>Recurrence rate (n, %)</td><td>9/39 (23%) **</td><td></td></tr>
            <tr><td>Follow-up duration (months)</td><td>26.7 ± 13.7</td><td>(3–66)</td></tr>

        </tbody>
    </table>

    <table-wrap-foot>
        <p>Values are given as median with interquartile range, or mean ± SD as appropriate.</p>
        <p>AH, atrium-His interval; BCL, baseline cycle length; °C, centigrade Celsius; HV, His-ventricular interval; IQR, interquartile range; RF, radiofrequency; SD, standard deviation; W, watts; WCL, Wenckebach cycle length.</p>
        <p>*The VAs were eliminated completely in 31 patients. In 4 patients RVOT originating PVCs, PVC burden was decreased more than 50% by Holter monitoring performed the next day. The procedures failed in 4 VT patients.</p>
        <p>**Four patients who developed recurrences underwent successful repeat ablations and 3 patients were followed-up with medical therapy without problems. The ablations could not be performed in 2 of the patients because the arrhythmic origin was closely associated with the coronary artery in the repeat study.</p>
    </table-wrap-foot>

</table-wrap>

<table-wrap id="tbl3">
    <label>Table 3</label>
    <caption>
        <title>Achieved ablation parameters during ablation with irrigated tip catheter according to the ventricular arrhythmia type</title>
    </caption>

    <table frame="hsides" rules="groups">
        <thead>
            <tr>
                <th>Ablation properties</th>
                <th>VT (n=14)</th>
                <th>PVC (n=25)</th>
                <th>p</th>
            </tr>
        </thead>
        <tbody>

            <tr>
                <td>RF lesion (n, mean ± SD)</td>
                <td>11.4 ± 8.5</td>
                <td>8.5 ± 5.9</td>
                <td>0.1</td>
            </tr>

            <tr><td><bold>Power</bold></td><td></td><td></td><td></td></tr>

            <tr>
                <td>&#160;&#160;Average (W, mean ± SD)</td>
                <td>22.8 ± 10.2</td>
                <td>26.4 ± 6.8</td>
                <td>0.2</td>
            </tr>

            <tr>
                <td>&#160;&#160;Maximum (W, median, 25th and 75th IQR)</td>
                <td>35.0 (24.3–41.5)</td>
                <td>35.0 (30.0–35.0)</td>
                <td>0.9</td>
            </tr>

            <tr><td><bold>Temperature</bold></td><td></td><td></td><td></td></tr>

            <tr>
                <td>&#160;&#160;Average (°C, median, 25th and 75th IQR)</td>
                <td>34.5 (31.0–53.3)</td>
                <td>32.0 (29.5–35.0)</td>
                <td>0.04<sup>*</sup></td>
            </tr>

            <tr>
                <td>&#160;&#160;Maximum (°C, median, 25th and 75th IQR)</td>
                <td>37.0 (32.8–60.3)</td>
                <td>32.0 (31.0–38.0)</td>
                <td>0.03<sup>*</sup></td>
            </tr>

            <tr><td><bold>Energy</bold></td><td></td><td></td><td></td></tr>

            <tr>
                <td>&#160;&#160;Average (joule, mean ± SD)</td>
                <td>859.4 ± 659.0</td>
                <td>1028.9 ± 651.0</td>
                <td>0.4</td>
            </tr>

            <tr>
                <td>Procedure time (min, mean ± SD)</td>
                <td>194.0 ± 60.3</td>
                <td>148.8 ± 41.4</td>
                <td>0.01<sup>*</sup></td>
            </tr>

        </tbody>
    </table>

    <table-wrap-foot>
        <p>Values are given as median with interquartile range, or mean ± SD as appropriate.</p>
        <p>°C, centigrade Celsius; IQR, interquartile range; PVC, premature ventricular complex; RF, radiofrequency; SD, standard deviation; VT, ventricular tachycardia; W, watts.</p>
        <p><sup>*</sup>p&lt;0.05</p>
    </table-wrap-foot>

</table-wrap>
		  
		
<table-wrap id="tbl4">
    <label>Table 4</label>
    <caption>
        <title>Properties of ablations according to history of prior ablation</title>
    </caption>

    <table frame="hsides" rules="groups">
        <thead>
            <tr>
                <th>Property</th>
                <th>Prior ablation (n=8)</th>
                <th>No prior ablation (n=31)</th>
                <th><italic>p</italic></th>
            </tr>
        </thead>
        <tbody>

            <tr>
                <td>RF lesion (n, mean ± SD)</td>
                <td>11.7 ± 5.4</td>
                <td>9.0 ± 5.9</td>
                <td>0.2</td>
            </tr>

            <tr>
                <td>Procedure time (min, mean ± SD)</td>
                <td>195.8 ± 69.7</td>
                <td>157.0 ± 45.9</td>
                <td>0.06</td>
            </tr>

            <tr>
                <td>MDI (%, mean ± SD)</td>
                <td>0.69 ± 0.15</td>
                <td>0.51 ± 0.12</td>
                <td>0.002<sup>*</sup></td>
            </tr>

            <tr>
                <td>Average temperature (°C, median, 25th and 75th IQR)</td>
                <td>34.5 (29.5–49.3)</td>
                <td>33.0 (30.0–36.0)</td>
                <td>0.55</td>
            </tr>

            <tr>
                <td>Average power (W, mean ± SD)</td>
                <td>23.4 ± 11.2</td>
                <td>25.6 ± 7.6</td>
                <td>0.5</td>
            </tr>

            <tr>
                <td>Energy (joule, mean ± SD)</td>
                <td>818.3 ± 773.2</td>
                <td>1006.7 ± 623.4</td>
                <td>0.47</td>
            </tr>

        </tbody>
    </table>

    <table-wrap-foot>
        <p>Values are given as median with interquartile range, or mean ± SD as appropriate.</p>
        <p>°C, Centigrade Celsius; IQR, interquartile range; MDI, maximum deflection index; RF, radiofrequency; SD, standard deviation; W, watts.</p>
        <p><sup>*</sup>p&lt;0.05</p>
    </table-wrap-foot>

</table-wrap>
		
		  <p>No fluoroscopy was used in 30 of the patients, while fluoroscopy was utilized in 9 of the patients. The fluoroscopy times ranged between 0.1 and 3 min in 4 patients and between 3 and 6 min in 3 patients. No significant differences were found between the fluoroscopy times and procedure times among the patients undergoing fluoroscopy in terms of the type and origin of the arrhythmia (<xref ref-type="table" rid="tbl5">Table 5</xref>). The ablation was initiated with a 7F, 4 mm standard non-irrigated catheter (Marinr; Medtronic Inc.) in 17 patients, and it was continued with an irrigated tip catheter when the first attempt failed. The procedure time was statistically shorter and less RF was delivered when the irrigated tip catheter was used as the first choice (<xref ref-type="table" rid="tbl6">Table 6</xref>). None of the patients developed complications.</p>
		  

<table-wrap id="tbl5">
    <label>Table 5</label>
    <caption>
        <title>Properties of the fluoroscopy used nine cases according to arrhythmia type and arrhythmia origin</title>
    </caption>

    <table frame="hsides" rules="groups">
        <thead>
            <tr>
                <th rowspan="2">Procedure characteristics (n=9)</th>
                <th colspan="3">Arrhythmia type</th>
                <th colspan="3">Arrhythmia origin</th>
            </tr>
            <tr>
                <th>VT (n=5)</th>
                <th>PVC (n=4)</th>
                <th><italic>p</italic></th>
                <th>Left sided (n=4)</th>
                <th>Right sided (n=5)</th>
                <th><italic>p</italic></th>
            </tr>
        </thead>

        <tbody>

            <tr>
                <td>
                    RF lesion, n, mean ± SD (range)
                    8.7 ± 5.7 (1.0–18.0)
                </td>
                <td>10.2 ± 5.7 (4.0–18.0)</td>
                <td>7.0 ± 6.0 (1.0–15.0)</td>
                <td>0.4</td>
                <td>6.8 ± 5.6 (1.0–14.0)</td>
                <td>10.4 ± 5.8 (4.0–18.0)</td>
                <td>0.4</td>
            </tr>

            <tr>
                <td>
                    Fluoroscopy time, min, mean ± SD (range)
                    5.2 ± 6.1 (0.2–18.4)
                </td>
                <td>7.9 ± 7.1 (2.6–18.4)</td>
                <td>1.8 ± 2.5 (0.2–5.5)</td>
                <td>0.1</td>
                <td>5.7 ± 8.5 (0.4–18.4)</td>
                <td>4.8 ± 4.6 (0.2–12.3)</td>
                <td>0.8</td>
            </tr>

            <tr>
                <td>
                    Procedure time, min, mean ± SD (range)
                    181.7 ± 50.6 (110.0–245.0)
                </td>
                <td>190.0 ± 62.4 (120.0–245.0)</td>
                <td>177.5 ± 49.7 (110.0–210.0)</td>
                <td>0.7</td>
                <td>170.0 ± 64.8 (110.0–240.0)</td>
                <td>191.0 ± 41.6 (140.0–245.0)</td>
                <td>0.6</td>
            </tr>

        </tbody>
    </table>

    <table-wrap-foot>
        <p>Values are given as count, mean ± SD and range.</p>
        <p>PVC, premature ventricular complex; RF, radiofrequency; SD, standard deviation; VT, ventricular tachycardia.</p>
    </table-wrap-foot>

</table-wrap>
		 

<table-wrap id="tbl6">
    <label>Table 6</label>
    <caption>
        <title>Properties of ablations according to being irrigated tip catheter as a first choice</title>
    </caption>

    <table frame="hsides" rules="groups">
        <thead>
            <tr>
                <th rowspan="2">Property</th>
                <th colspan="2">Irrigated tip catheter as a first choice</th>
                <th rowspan="2"><italic>p</italic></th>
            </tr>
            <tr>
                <th>Yes (n=22/39)</th>
                <th>No (n=17/39)</th>
            </tr>
        </thead>

        <tbody>

            <tr>
                <td>RF lesion (n, mean ± SD)</td>
                <td>7.5 ± 5.5</td>
                <td>12.1 ± 5.5</td>
                <td>0.01<sup>*</sup></td>
            </tr>

            <tr><td><bold>Power</bold></td><td></td><td></td><td></td></tr>

            <tr>
                <td>&#160;&#160;Average (W, mean ± SD)</td>
                <td>25.5 ± 7.5</td>
                <td>24.7 ± 9.5</td>
                <td>0.8</td>
            </tr>

            <tr>
                <td>&#160;&#160;Maximum (W, median, 25th and 75th IQR)</td>
                <td>35.0 (33.7–35.0)</td>
                <td>30.0 (30.0–35.0)</td>
                <td>0.17</td>
            </tr>

            <tr><td><bold>Temperature</bold></td><td></td><td></td><td></td></tr>

            <tr>
                <td>&#160;&#160;Average (°C, median, 25th and 75th IQR)</td>
                <td>32.5 (29.8–35.3)</td>
                <td>33.0 (30.5–43.0)</td>
                <td>0.3</td>
            </tr>

            <tr>
                <td>&#160;&#160;Maximum (°C, median, 25th and 75th IQR)</td>
                <td>32.5 (31.0–39.0)</td>
                <td>36.0 (31.5–46.5)</td>
                <td>0.16</td>
            </tr>

            <tr><td><bold>Energy</bold></td><td></td><td></td><td></td></tr>

            <tr>
                <td>&#160;&#160;Average (joule, mean ± SD)</td>
                <td>929.3 ± 458.7</td>
                <td>1018.1 ± 850</td>
                <td>0.7</td>
            </tr>

            <tr>
                <td>Procedure time (min, mean ± SD)</td>
                <td>142.7 ± 40.8</td>
                <td>193.9 ± 54.0</td>
                <td>0.02<sup>*</sup></td>
            </tr>

        </tbody>
    </table>

    <table-wrap-foot>
        <p>Values are given as median with interquartile range, or mean ± SD as appropriate.</p>
        <p>°C, Centigrade Celsius; IQR, interquartile range; RF, radiofrequency; SD, standard deviation; W, watts.</p>
        <p><sup>*</sup>p&lt;0.05</p>
    </table-wrap-foot>

</table-wrap>
		
		  <p>During a mean follow-up time of 26.7 ± 13.7 months, the VAs recurred in 9 of the patients (23%). Five of the patients who developed recurrences had RVOT VT and 4 had RVOT PVCs. Repeat ablations were performed successfully in 4 of the patients who developed recurrences. Three of the patients who developed recurrences were followed up with sotalol, flecainide, and propranolol without problems. The remaining two patients with recurrences underwent the ablation procedure again. Despite the fact that right-sided ablations were previously performed successfully in these two patients, the ablation could not be carried out in the second procedure because the target point was mapped very close to the coronary artery. These patients were followed up with antiarrhythmic medications.</p>
		  
	  </sec>
	  
      <sec>
		  <title>Discussion</title>
        <p>Although there are studies regarding the use of irrigated catheters in adult catheter ablations and pediatric supraventricular tachycardia catheter ablations, there are insufficient studies regarding the use of irrigated catheters with 3DMS guidance in pediatric VA ablations.<xref ref-type="bibr" rid="BIBR-7"><sup>7</sup></xref><xref ref-type="bibr" rid="BIBR-8"><sup>8</sup></xref><xref ref-type="bibr" rid="BIBR-9"><sup>9</sup></xref><xref ref-type="bibr" rid="BIBR-10"><sup>10</sup></xref><xref ref-type="bibr" rid="BIBR-11"><sup>11</sup></xref><xref ref-type="bibr" rid="BIBR-12"><sup>12</sup></xref> This study indicated that irrigated catheters can be used with high success and reliability rates in VA catheter ablations in pediatric patients.</p><p>In school screening programs, the VA incidence in children was 0.2–0.8/10,000, which is less than that in adult patients.<xref ref-type="bibr" rid="BIBR-13"><sup>13</sup></xref><xref ref-type="bibr" rid="BIBR-14"><sup>14</sup></xref> As seen in the present study, most pediatric VAs have RVOT origins, and they can be successfully treated with catheter ablations at a rate of 60–90%.<xref ref-type="bibr" rid="BIBR-14"><sup>14</sup></xref><xref ref-type="bibr" rid="BIBR-15"><sup>15</sup></xref><xref ref-type="bibr" rid="BIBR-16"><sup>16</sup></xref><xref ref-type="bibr" rid="BIBR-17"><sup>17</sup></xref></p><p>In our study, the VAs were successfully ablated from the left ventricular outflow tract (LVOT) in 3 patients. In the evaluation of 2 of the patients who previously underwent successful RVOT VA ablations, the target point was close to the coronary artery in the second study. However, the number of such cases will increase with advancements and experience in mapping technology. The proximity to the coronary artery should be carefully assessed when a VA ablation is performed from the LVOT in order to avoid catastrophic coronary complications. In our clinic, we begin mapping from the RVOT in terms of procedural safety in all pediatric patients. No complications were seen in any of the patients in our study.</p><p>The procedures were performed in all of the patients with the guidance of 3DMS using limited/zero fluoroscopy. Limited fluoroscopy was used in 9 of the 39 patients. Overall, the radiation dose is proportional to the lifelong cancer risk, and this association is important for both pediatric patients with long life expectancy and laboratory personnel.<xref ref-type="bibr" rid="BIBR-18"><sup>18</sup></xref><xref ref-type="bibr" rid="BIBR-19"><sup>19</sup></xref> In addition to decreasing the use of fluoroscopy, 3DMS also increases the success of the procedure. The important advantages of this system include the clear definition of the anatomical structures and the ability to re-access the same anatomical point when desired.</p><p>All of our patients who developed recurrences had RVOT-originating VAs. However, no recurrences were found in any of the patients with LVOT-originating VAs who underwent successful ablations. This may be because of the better catheter stability in the aortic cusps and the easier retroaortic catheter manipulation when compared to the RVOT.</p><p>The RF energy could not be delivered in 2 of the patients who previously underwent successful ablations and developed recurrences during the follow-up because the ablation target was close to the coronary artery. In such cases, it is a safe approach to postpone the operation until the patient grows. The pediatric patient group has a long life expectancy, experience with coronary interventions in this population is limited, and effective medication alternatives are available.</p><p>Deeper lesions are created with irrigated catheters when compared to non-irrigated catheters, making them more effective in epicardial-localized arrhythmia foci. In addition, the formation of coagulum and thrombi is lower.<xref ref-type="bibr" rid="BIBR-20"><sup>20</sup></xref> In our study, there were higher MDI values in the 8 patients who previously underwent failed VA ablations than in the patients who underwent ablations for the first time in our clinic, which is consistent with this situation. An irrigated catheter was used as the first choice in more than 50% (22/39, 56%) of our patients. Moreover, the number of RF lesions and procedure time, which are the risk factors for complications, were less in this group than in the other patient group. An irrigated catheter can be chosen as the first option in RFAs of pediatric VAs. However, future randomized controlled studies will reach more definitive results. The literature states that the risk of steam pops increases when the RF power rises above 30 W; however, no audible steam pops were observed in our study.<xref ref-type="bibr" rid="BIBR-20"><sup>20</sup></xref></p><p>In our study group, before the ablation, mild left ventricular dysfunction was found in 3 patients and dilated cardiomyopathy was found in one patient; however, the cardiac functions improved in these patients after the ablation. Tachycardia-mediated cardiomyopathy (TMC) has been more commonly defined in supraventricular arrhythmias and in idiopathic ventricular outflow tract tachycardia.<xref ref-type="bibr" rid="BIBR-21"><sup>21</sup></xref><xref ref-type="bibr" rid="BIBR-22"><sup>22</sup></xref><xref ref-type="bibr" rid="BIBR-23"><sup>23</sup></xref><xref ref-type="bibr" rid="BIBR-24"><sup>24</sup></xref> The improved cardiac functions in our 4 patients after their ablations indicated that the current conditions were TMCs, and successful ablation treatments are important in children with long life expectancies.</p><p>A successful PVC ablation was performed in one 14-year-old patient who was followed up with the diagnosis of long QT because of PVCs that triggered an ICD storm. Although there are similar cases in the literature, no pediatric case has been reported thus far.<xref ref-type="bibr" rid="BIBR-25"><sup>25</sup></xref><xref ref-type="bibr" rid="BIBR-26"><sup>26</sup></xref></p><p>Alcohol ablation, coil embolization, simultaneous unipolar or bipolar RF ablation, surgical ablation, and noninvasive ablation with stereotactic radiosurgery can be performed in adults in order to increase the VA ablation success rate; however, it is obvious that further studies and experience are needed in order to apply these methods in pediatric patients.<xref ref-type="bibr" rid="BIBR-6"><sup>6</sup></xref> In one study evaluating epicardial ablations in pediatric patients, with 50% of 10 procedures being VA ablations in 9 pediatric patients, it was reported that epicardial ablations can be carried out in resistant VAs.<xref ref-type="bibr" rid="BIBR-27"><sup>27</sup></xref> However, further studies are needed in order to use epicardial ablations, which are being increasingly performed in adult patient groups, in pediatric VA patients.</p><p>The limitations of this study include its single-center and retrospective design, as well as the limited number of patients because VAs are seen infrequently in children. The relatively short follow-up duration was another limitation. Finally, the lack of a control group without the use of 3DMS was another limiting factor.</p>
    </sec>
	  <sec><title>Conclusion</title><p>Irrigated catheters can be used with high success and low complication rates in VA ablations with the guidance of 3DMS in pediatric patients. The use of fluoroscopy can be significantly limited in irrigated VA ablations using 3DMS, and successful ablations can be performed in most cases with zero fluoroscopy.</p></sec>
  </body>
  <back>
    
    <sec>
      <title>Funding</title>
      <p>The authors state that the current study received no financial support.</p>
    </sec>
    <sec sec-type="how-to-cite">
      <title>How to Cite</title>
      <p>Koca S, Akdeniz C, Tuzcu V. Irrigated Radiofrequency Catheter Ablation with Limited Fluoroscopy for Ventricular Arrhythmias in Children and Adolescents. J Arrhythm Electrophysiol. 2023;1(1):1-9.</p>
    </sec>
    
	  <ref-list>
<title>References</title>

<ref id="BIBR-1">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Simao</surname><given-names>MF</given-names></name>
<name><surname>Rios</surname><given-names>MN</given-names></name>
<name><surname>Leiria</surname><given-names>TL</given-names></name>
<etal/>
</person-group>
<article-title>Electrophysiological studies and radiofrequency ablations in children and adolescents with arrhythmia</article-title>
<source>Arq Bras Cardiol</source>
<year>2015</year>
<volume>104</volume>
<issue>1</issue>
<fpage>53</fpage>
<lpage>57</lpage>
</element-citation>
</ref>

<ref id="BIBR-2">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Kubus</surname><given-names>P</given-names></name>
<name><surname>Vit</surname><given-names>P</given-names></name>
<name><surname>Gebauer</surname><given-names>RA</given-names></name>
<etal/>
</person-group>
<article-title>Long-term results of paediatric radiofrequency catheter ablation: a population-based study</article-title>
<source>Europace</source>
<year>2014</year>
<volume>16</volume>
<issue>12</issue>
<fpage>1808</fpage>
<lpage>1813</lpage>
</element-citation>
</ref>

<ref id="BIBR-3">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>XM</given-names></name>
<name><surname>Jiang</surname><given-names>H</given-names></name>
<name><surname>Li</surname><given-names>YH</given-names></name>
<etal/>
</person-group>
<article-title>Effectiveness of Radiofrequency Catheter Ablation of Outflow Tract Ventricular Arrhythmias in Children and Adolescents</article-title>
<source>Pediatr Cardiol</source>
<year>2016</year>
<volume>37</volume>
<issue>8</issue>
<fpage>1475</fpage>
<lpage>1481</lpage>
</element-citation>
</ref>

<ref id="BIBR-4">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Van Hare</surname><given-names>GF</given-names></name>
<name><surname>Javitz</surname><given-names>H</given-names></name>
<name><surname>Carmelli</surname><given-names>D</given-names></name>
<etal/>
</person-group>
<article-title>Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes</article-title>
<source>J Cardiovasc Electrophysiol</source>
<year>2004</year>
<volume>15</volume>
<issue>7</issue>
<fpage>759</fpage>
<lpage>770</lpage>
</element-citation>
</ref>

<ref id="BIBR-5">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>DT</given-names></name>
<name><surname>Gerstenfeld</surname><given-names>EP</given-names></name>
<name><surname>Tzou</surname><given-names>WS</given-names></name>
<etal/>
</person-group>
<article-title>Radiofrequency Ablation Using an Open Irrigated Electrode Cooled With Half-Normal Saline</article-title>
<source>JACC Clin Electrophysiol</source>
<year>2017</year>
<volume>3</volume>
<issue>10</issue>
<fpage>1103</fpage>
<lpage>1110</lpage>
</element-citation>
</ref>

<ref id="BIBR-6">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Gianni</surname><given-names>C</given-names></name>
<name><surname>Mohanty</surname><given-names>S</given-names></name>
<name><surname>Trivedi</surname><given-names>C</given-names></name>
<etal/>
</person-group>
<article-title>Alternative Approaches for Ablation of Resistant Ventricular Tachycardia</article-title>
<source>Card Electrophysiol Clin</source>
<year>2017</year>
<volume>9</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>98</lpage>
</element-citation>
</ref>

<!-- Devam ediyor -->

<ref id="BIBR-7">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Mussigbrodt</surname><given-names>A</given-names></name>
<name><surname>Grothoff</surname><given-names>M</given-names></name>
<name><surname>Dinov</surname><given-names>B</given-names></name>
<etal/>
</person-group>
<article-title>Irrigated tip catheters for radiofrequency ablation in ventricular tachycardia</article-title>
<source>Biomed Res Int</source>
<year>2015</year>
<volume>2015</volume>
<fpage>389294</fpage>
</element-citation>
</ref>

<ref id="BIBR-8">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Hamaya</surname><given-names>R</given-names></name>
<name><surname>Miyazaki</surname><given-names>S</given-names></name>
<name><surname>Kajiyama</surname><given-names>T</given-names></name>
<etal/>
</person-group>
<article-title>Efficacy and safety comparison between different types of novel design enhanced open-irrigated ablation catheters in creating cavo-tricuspid isthmus block</article-title>
<source>J Cardiol</source>
<year>2018</year>
<volume>71</volume>
<issue>5</issue>
<fpage>513</fpage>
<lpage>516</lpage>
</element-citation>
</ref>

<ref id="BIBR-9">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Tanner</surname><given-names>H</given-names></name>
<name><surname>Hindricks</surname><given-names>G</given-names></name>
<name><surname>Volkmer</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study</article-title>
<source>J Cardiovasc Electrophysiol</source>
<year>2010</year>
<volume>21</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>53</lpage>
</element-citation>
</ref>

<ref id="BIBR-10">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Gulletta</surname><given-names>S</given-names></name>
<name><surname>Tsiachris</surname><given-names>D</given-names></name>
<name><surname>Radinovic</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>Safety and efficacy of open irrigated-tip catheter ablation of Wolff-Parkinson-White syndrome in children and adolescents</article-title>
<source>Pacing Clin Electrophysiol</source>
<year>2013</year>
<volume>36</volume>
<issue>4</issue>
<fpage>486</fpage>
<lpage>490</lpage>
</element-citation>
</ref>

<ref id="BIBR-11">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Yamane</surname><given-names>T</given-names></name>
<name><surname>Jais</surname><given-names>P</given-names></name>
<name><surname>Shah</surname><given-names>DC</given-names></name>
<etal/>
</person-group>
<article-title>Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation</article-title>
<source>Circulation</source>
<year>2000</year>
<volume>102</volume>
<issue>21</issue>
<fpage>2565</fpage>
<lpage>2568</lpage>
</element-citation>
</ref>

<ref id="BIBR-12">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Marchlinski</surname><given-names>FE</given-names></name>
<name><surname>Haffajee</surname><given-names>CI</given-names></name>
<name><surname>Beshai</surname><given-names>JF</given-names></name>
<etal/>
</person-group>
<article-title>Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial</article-title>
<source>J Am Coll Cardiol</source>
<year>2016</year>
<volume>67</volume>
<issue>6</issue>
<fpage>674</fpage>
<lpage>683</lpage>
</element-citation>
</ref>

<ref id="BIBR-13">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Iwamoto</surname><given-names>M</given-names></name>
<name><surname>Niimura</surname><given-names>I</given-names></name>
<name><surname>Shibata</surname><given-names>T</given-names></name>
<etal/>
</person-group>
<article-title>Long-term course and clinical characteristics of ventricular tachycardia detected in children by school-based heart disease screening</article-title>
<source>Circ J</source>
<year>2005</year>
<volume>69</volume>
<issue>3</issue>
<fpage>273</fpage>
<lpage>276</lpage>
</element-citation>
</ref>

<ref id="BIBR-14">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Pfammatter</surname><given-names>JP</given-names></name>
<name><surname>Paul</surname><given-names>T</given-names></name>
</person-group>
<article-title>Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome</article-title>
<source>J Am Coll Cardiol</source>
<year>1999</year>
<volume>33</volume>
<issue>7</issue>
<fpage>2067</fpage>
<lpage>2072</lpage>
</element-citation>
</ref>

<ref id="BIBR-15">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>HE</given-names></name>
<name><surname>Kriebel</surname><given-names>T</given-names></name>
<name><surname>Jung</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>Catheter ablation of idiopathic left and right ventricular tachycardias in the pediatric population using noncontact mapping</article-title>
<source>Heart Rhythm</source>
<year>2010</year>
<volume>7</volume>
<issue>6</issue>
<fpage>731</fpage>
<lpage>739</lpage>
</element-citation>
</ref>

<ref id="BIBR-16">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Miszczak-Knecht</surname><given-names>M</given-names></name>
<name><surname>Szumowski</surname><given-names>L</given-names></name>
<name><surname>Posadowska</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Idiopathic ventricular arrhythmia in children and adolescents: early effectiveness of radiofrequency current ablation</article-title>
<source>Kardiol Pol</source>
<year>2014</year>
<volume>72</volume>
<issue>11</issue>
<fpage>1148</fpage>
<lpage>1155</lpage>
</element-citation>
</ref>

<ref id="BIBR-17">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Ozyilmaz</surname><given-names>I</given-names></name>
<name><surname>Ergul</surname><given-names>Y</given-names></name>
<name><surname>Akdeniz</surname><given-names>C</given-names></name>
<etal/>
</person-group>
<article-title>Catheter ablation of idiopathic ventricular tachycardia in children using the EnSite NavX system with/without fluoroscopy</article-title>
<source>Cardiol Young</source>
<year>2014</year>
<volume>24</volume>
<issue>5</issue>
<fpage>886</fpage>
<lpage>892</lpage>
</element-citation>
</ref>

<ref id="BIBR-18">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Einstein</surname><given-names>AJ</given-names></name>
</person-group>
<article-title>Medical imaging: the radiation issue</article-title>
<source>Nat Rev Cardiol</source>
<year>2009</year>
<volume>6</volume>
<issue>6</issue>
<fpage>436</fpage>
<lpage>438</lpage>
</element-citation>
</ref>

<ref id="BIBR-19">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Justino</surname><given-names>H</given-names></name>
</person-group>
<article-title>The ALARA concept in pediatric cardiac catheterization: techniques and tactics for managing radiation dose</article-title>
<source>Pediatr Radiol</source>
<year>2006</year>
<volume>36</volume>
<issue>Suppl 2</issue>
<fpage>146</fpage>
<lpage>153</lpage>
</element-citation>
</ref>

<ref id="BIBR-20">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Houmsse</surname><given-names>M</given-names></name>
<name><surname>Daoud</surname><given-names>EG</given-names></name>
</person-group>
<article-title>Biophysics and clinical utility of irrigated-tip radiofrequency catheter ablation</article-title>
<source>Expert Rev Med Devices</source>
<year>2012</year>
<volume>9</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>70</lpage>
</element-citation>
</ref>

<ref id="BIBR-21">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Horenstein</surname><given-names>MS</given-names></name>
<name><surname>Saarel</surname><given-names>E</given-names></name>
<name><surname>Dick</surname><given-names>M</given-names></name>
<name><surname>Karpawich</surname><given-names>PP</given-names></name>
</person-group>
<article-title>Reversible symptomatic dilated cardiomyopathy in older children and young adolescents due to primary non-sinus supraventricular tachyarrhythmias</article-title>
<source>Pediatr Cardiol</source>
<year>2003</year>
<volume>24</volume>
<issue>3</issue>
<fpage>274</fpage>
<lpage>279</lpage>
</element-citation>
</ref>

<ref id="BIBR-22">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Nakazato</surname><given-names>Y</given-names></name>
</person-group>
<article-title>Tachycardiomyopathy</article-title>
<source>Indian Pacing Electrophysiol J</source>
<year>2002</year>
<volume>2</volume>
<issue>4</issue>
<fpage>104</fpage>
<lpage>113</lpage>
</element-citation>
</ref>

<ref id="BIBR-23">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Grimm</surname><given-names>W</given-names></name>
<name><surname>Menz</surname><given-names>V</given-names></name>
<name><surname>Hoffmann</surname><given-names>J</given-names></name>
<name><surname>Maisch</surname><given-names>B</given-names></name>
</person-group>
<article-title>Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia</article-title>
<source>Pacing Clin Electrophysiol</source>
<year>2001</year>
<volume>24</volume>
<issue>2</issue>
<fpage>166</fpage>
<lpage>171</lpage>
</element-citation>
</ref>

<ref id="BIBR-24">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Jaggarao</surname><given-names>NS</given-names></name>
<name><surname>Nanda</surname><given-names>AS</given-names></name>
<name><surname>Daubert</surname><given-names>JP</given-names></name>
</person-group>
<article-title>Ventricular tachycardia induced cardiomyopathy: improvement with radiofrequency ablation</article-title>
<source>Pacing Clin Electrophysiol</source>
<year>1996</year>
<volume>19</volume>
<issue>4 Pt 1</issue>
<fpage>505</fpage>
<lpage>508</lpage>
</element-citation>
</ref>

<ref id="BIBR-25">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>Z</given-names></name>
<name><surname>Gao</surname><given-names>P</given-names></name>
<name><surname>Cheng</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>Elimination of fatal arrhythmias through ablation of triggering premature ventricular contraction in type 3 long QT syndrome</article-title>
<source>Ann Noninvasive Electrocardiol</source>
<year>2012</year>
<volume>17</volume>
<issue>4</issue>
<fpage>394</fpage>
<lpage>397</lpage>
</element-citation>
</ref>

<ref id="BIBR-26">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Sato</surname><given-names>A</given-names></name>
<name><surname>Chinushi</surname><given-names>M</given-names></name>
<name><surname>Sonoda</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>Benign premature ventricular complexes from the right ventricular outflow tract triggered polymorphic ventricular tachycardia in a latent type 2 LQTS patient</article-title>
<source>Intern Med</source>
<year>2012</year>
<volume>51</volume>
<issue>23</issue>
<fpage>3261</fpage>
<lpage>3265</lpage>
</element-citation>
</ref>

<ref id="BIBR-27">
<element-citation publication-type="article-journal">
<person-group person-group-type="author">
<name><surname>Upadhyay</surname><given-names>S</given-names></name>
<name><surname>Walsh</surname><given-names>EP</given-names></name>
<name><surname>Cecchin</surname><given-names>F</given-names></name>
<etal/>
</person-group>
<article-title>Epicardial ablation of tachyarrhythmia in children: Experience at two academic centers</article-title>
<source>Pacing Clin Electrophysiol</source>
<year>2017</year>
<volume>40</volume>
<issue>9</issue>
<fpage>1017</fpage>
<lpage>1026</lpage>
</element-citation>
</ref>
</ref-list>	  
  </back>
</article>